The ALS therapy candidate AP-101 significantly extended patient survival and delayed the need for respiratory support in a ...
A new gene therapy, Celosia's CTx1000, is now being tested for ALS in a small clinical trial in Australia. The one-time treatment targets toxic TDP-43 protein clumps, a key driver of most cases of ALS ...
Elon Musk highlights Neuralink’s latest breakthrough as ALS patient Kenneth Shock regains ability to communicate. The brain ...
Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims ...
A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...
India Today on MSN
Meet the man who speaks with his mind, Neuralink chip gives ALS patient a voice again
An ALS patient named Kenneth shares how a Neuralink brain implant restored his ability to communicate in his own voice ...
An experimental oral therapy was well-tolerated and linked to lower risks for ALS complications, according to findings of a phase 2b randomized controlled trial published in JAMA Neurology.“The ...
Researchers have uncovered a surprising connection between gut bacteria and the development of ALS and frontotemporal ...
In just its first six months on the streets, Engine 2031 has rolled on 128 advanced life support calls across the city and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results